This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: University of Illinois. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Noah Bindman
Introduction
Noah Bindman is an accomplished inventor based in Seattle, WA. He has made significant strides in the field of cancer research, particularly through his innovative work on FOXM1 inhibitors. His contributions are vital in the ongoing battle against various forms of cancer, especially breast cancer.
Latest Patents
Noah Bindman holds a patent for "FOXM1 inhibitor compositions and methods of using the same." This patent includes compounds and their pharmaceutically acceptable salts that are effective in inhibiting FOXM1, which plays a crucial role in cancer growth. The compounds developed by Bindman are particularly useful in treating different forms of breast cancer.
Career Highlights
Bindman is affiliated with the University of Illinois, where he continues to advance his research and innovation in cancer treatment. His work has garnered attention for its potential to improve therapeutic options for patients suffering from breast cancer.
Collaborations
Throughout his career, Noah Bindman has collaborated with notable colleagues, including John A. Katzenellenbogen and Benita Katzenellenbogen. These partnerships have enhanced the scope and impact of his research efforts.
Conclusion
Noah Bindman's innovative work in developing FOXM1 inhibitors represents a significant advancement in cancer treatment. His dedication to research and collaboration with esteemed colleagues underscores the importance of innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile